View Procedure
Procedure Name | Formulation Approval For Borderline products | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description |
Process Steps
*This information may be subject to change in the future by the NMRA
| ||||||||||||||||||||||||||||||||||
Category | Import |
The following form/s are used in this procedure
Title | Description | Created Date | Updated Date | Issued By | |
---|---|---|---|---|---|
Checklist for evaluation of borderline products | Checklist for evaluation of borderline products | 05-07-2018 | 05-07-2018 |
This procedure applies to the following measures
Name | Measure Type | Agency | Description | Comments | Legal Document | Validity To | Measure Class |
---|---|---|---|---|---|---|---|
Formulation Approval For Borderline products | Permit Requirement | Formulation approval For Borderline products for foreign products. | Formulation approval For Borderline products for foreign products. | National Medicines Regulatory Authority Act | 08-12-9999 | Good |